Singapore markets open in 6 hours 12 minutes
Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,073.47 +62.87 (+1.25%) Dow
38,505.43 +265.45 (+0.69%) Nasdaq
15,723.62 +272.31 (+1.76%) Bitcoin USD
66,703.91 +248.11 (+0.37%) CMC Crypto 200
1,436.91 +22.15 (+1.57%)
Samsung Biologics Co.,Ltd. (207940.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
| Previous close | 802,000.00 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 71,525 |
| Market cap | 56.299T |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1,024,500.00 |
PR NewswireSamsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)
Samsung Life Science Fund, created jointly between Samsung Biologics (KRX: 207940.KS), Samsung Bioepis, and Samsung C&T (KRX: 028260.KS), and managed by Samsung Ventures, and BrickBio, Inc. announced Samsung's investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.
- Thomson Reuters StreetEvents
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
PR NewswireSamsung Biologics awarded Leadership status by CDP for climate action efforts
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced that it has received the Leadership status and A- rating from the Carbon Disclosure Project (CDP).
© 2024 Yahoo. All rights reserved.